Associations of mortality with own blood pressure using son's blood pressure as an instrumental variable.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 06 2019
Historique:
received: 15 02 2019
accepted: 28 05 2019
entrez: 22 6 2019
pubmed: 22 6 2019
medline: 22 10 2020
Statut: epublish

Résumé

High systolic blood pressure (SBP) causes cardiovascular disease (CVD) and is associated with mortality from other causes, but conventional multivariably-adjusted results may be confounded. Here we used a son's SBP (>1 million Swedish men) as an instrumental variable for parental SBP and examined associations with parents' cause-specific mortality, avoiding reverse causation. The hazard ratio for CVD mortality per SD (10.80 mmHg) of SBP was 1.49 (95% CI: 1.43, 1.56); SBP was positively associated with coronary heart disease and stroke. SBP was also associated positively with all-cause, diabetes and kidney cancer mortality, and negatively with external causes. Negative associations with respiratory-related mortality were probably confounded by smoking. Hazard ratios for other causes were imprecise or null. Diastolic blood pressure gave similar results to SBP. CVD hazard ratios were intermediate between those from conventional multivariable studies and Mendelian randomization and stronger than those from clinical trials, approximately consistent with an effect of exposure duration on effect sizes. Plots of parental mortality against offspring SBP were approximately linear, supporting calls for lower SBP targets. Results suggest that conventional multivariable analyses of mortality and SBP are not substantially confounded by reverse causation and confirm positive effects of SBP on all-cause, CVD and diabetes mortality.

Identifiants

pubmed: 31222129
doi: 10.1038/s41598-019-45391-w
pii: 10.1038/s41598-019-45391-w
pmc: PMC6586810
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8986

Subventions

Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12013/9
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12013/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12013/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009351/1
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Lancet. 2007 Dec 1;370(9602):1829-39
pubmed: 18061058
Hypertension. 2009 Sep;54(3):509-15
pubmed: 19597042
BMJ. 2012 Jan 13;344:d8218
pubmed: 22246268
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
Hypertension. 2014 May;63(5):934-41
pubmed: 24637660
Medicina (Kaunas). 2016;52(2):89-98
pubmed: 27170481
Lancet. 2014 May 31;383(9932):1899-911
pubmed: 24881994
Stroke. 2012 Feb;43(2):432-40
pubmed: 22156683
Clin Auton Res. 2007 Apr;17(2):69-76
pubmed: 17106628
Lancet. 1998 Dec 5;352(9143):1801-7
pubmed: 9851379
Lancet. 1995 Apr 1;345(8953):825-9
pubmed: 7898229
J Hum Hypertens. 2002 Feb;16(2):91-6
pubmed: 11850765
Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2307-17
pubmed: 20826833
Lancet. 2016 Mar 5;387(10022):957-967
pubmed: 26724178
Lancet. 1995 Dec 23-30;346(8991-8992):1647-53
pubmed: 8551820
BMJ. 2011 Aug 25;343:d4891
pubmed: 21868454
Circulation. 1995 Nov 1;92(9):2437-45
pubmed: 7586343
J Am Geriatr Soc. 2018 Jan;66(1):205-206
pubmed: 29130478
BMJ. 2011 Feb 22;342:d643
pubmed: 21343202
J Hypertens. 2017 Jul;35(7):1333-1344
pubmed: 28157813
J Hypertens. 2009 Apr;27(4):673-9
pubmed: 19516168
Int J Epidemiol. 2016 Dec 1;45(6):1866-1886
pubmed: 28108528
Circulation. 2017 Jun 13;135(24):2357-2368
pubmed: 28432148
J Epidemiol Community Health. 2007 Jan;61(1):53-8
pubmed: 17183016
Circ Res. 2015 Mar 13;116(6):925-36
pubmed: 25767281
Lancet. 2001 Feb 3;357(9253):348-53
pubmed: 11210997
J Hypertens. 1998 Jul;16(7):941-7
pubmed: 9794734
Am J Epidemiol. 1979 Sep;110(3):304-12
pubmed: 474567
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
Medicine (Baltimore). 2015 Apr;94(16):e753
pubmed: 25906108
Econ Hum Biol. 2013 Jul;11(3):351-9
pubmed: 22560304
Ann Intern Med. 2015 Feb 3;162(3):184-91
pubmed: 25531552
Am J Med. 2002 Apr 15;112(6):479-86
pubmed: 11959059
Sci Rep. 2017 Apr 07;7:44808
pubmed: 28387226
Hypertension. 2001 Feb;37(2):187-93
pubmed: 11230269
N Engl J Med. 1996 Jan 4;334(1):13-8
pubmed: 7494564
Hypertension. 2014 Jun;63(6):1182-8
pubmed: 24591335
Am J Med. 2017 Jun;130(6):707-719.e8
pubmed: 28109971
Sci Rep. 2015 Jul 22;5:12399
pubmed: 26198310
BMC Public Health. 2017 Oct 10;17(1):797
pubmed: 29017534
J Hypertens. 2016 Jan;34(1):149-55
pubmed: 26630217
Sci Rep. 2017 Mar 20;7:44877
pubmed: 28317900
Diabetes Care. 2011 May;34 Suppl 2:S308-12
pubmed: 21525474
Curr Hypertens Rep. 2013 Apr;15(2):89-94
pubmed: 23344662
Hum Mol Genet. 2014 Sep 15;23(R1):R89-98
pubmed: 25064373
Int J Epidemiol. 1996 Feb;25(1):22-31
pubmed: 8666495
Sci Rep. 2016 Aug 11;6:31358
pubmed: 27511796
Am J Epidemiol. 2007 Feb 1;165(3):294-301
pubmed: 17098820
JAMA. 1999 Oct 27;282(16):1523-9
pubmed: 10546691
J Hypertens. 2003 Apr;21(4):707-16
pubmed: 12658016
BMJ. 2009 Dec 22;339:b5043
pubmed: 20028778
Ann Epidemiol. 2007 Jul;17(7):511-3
pubmed: 17466535
J Hypertens. 2011 Jan;29(1):4-16
pubmed: 20881867
Epidemiology. 2006 Jul;17(4):360-72
pubmed: 16755261
Hypertension. 2012 Apr;59(4):802-10
pubmed: 22353615
Diabetes. 2017 Feb;66(2):543-550
pubmed: 27702834
Epidemiology. 2015 Jul;26(4):498-504
pubmed: 25978796
Ann Oncol. 2010 Mar;21(3):640-645
pubmed: 19759188
Circulation. 2010 May 25;121(20):2160-1
pubmed: 20458007
Yonsei Med J. 2002 Apr;43(2):160-4
pubmed: 11971209
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
Circ Cardiovasc Genet. 2015 Dec;8(6):832-41
pubmed: 26538566
Nature. 2011 Sep 11;478(7367):103-9
pubmed: 21909115

Auteurs

David Carslake (D)

MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK. David.Carslake@bristol.ac.uk.
Population Health Sciences, Bristol Medical School, Bristol, UK. David.Carslake@bristol.ac.uk.

Abigail Fraser (A)

MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, Bristol, UK.

Margaret T May (MT)

Population Health Sciences, Bristol Medical School, Bristol, UK.

Tom Palmer (T)

Department of Mathematics and Statistics, University of Lancaster, Lancaster, UK.

Karri Silventoinen (K)

Population Research Unit, Department of Social Research, University of Helsinki, Helsinki, Finland.

Per Tynelius (P)

Department of Public Health Sciences, Karolinska Institute, Stockholm, Sweden.

Debbie A Lawlor (DA)

MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, Bristol, UK.

George Davey Smith (G)

MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH